Mentions
Extended reach
Total likes
Video views
AI synopsis
Discussions emphasize the promising response rate of 67% and mention factors like lower lactate levels and vasopressin use as predictors of response, indicating a constructive, data-driven conversation. The tone varies from cautious optimism to calls for further collaboration, reflecting both interest and engagement in understanding and applying the findings.
Most discussions recognize the main findings, especially the 67% response rate and the potential benefits of Angiotensin II, indicating agreement or positive acknowledgment.
The focus on new research findings and implications for treatment shows high interest among the posters.
Posts reference specific data points, such as response rates and factors like lactate levels, demonstrating a moderate level of engagement.
The discussions highlight potential clinical impact and the importance of collaborative research, suggesting a perception of moderate to high influence.
#JournalWatch Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use “...for vasopressor-refractory shock, 67% of angiotensin II recipients [had] a favorable hemodynamic response.” #critPRN #PharmICU @pwierusz @erin_barreto https://t.co/yE6FZxAXHo
@pwierusz @erin_barreto @EricaWittwer @kianoushbk @ogi_gajic et al found that 67% of angio II recipients had favorable hemodynamic response and mortality. Pts w/ lower lactate and those receiving vasopressin were more likely to respond to angio II. https://t.co/ACLlmVXyhb
Post-marketing use for vasopressor-refractory shock, 67% of angiotensin II recipients experienced favorable hemodynamic response. Pts w/ lower lactate or on vasopressin were more likely to respond. Angio II responders had lower mortality @SCCM @accpchest https://t.co/meRN3ROs01
RT @MayoPCCM: @pwierusz @erin_barreto @EricaWittwer @kianoushbk @ogi_gajic et al found that 67% of angio II recipients had favorable hemody…
RT @MayoPCCM: @pwierusz @erin_barreto @EricaWittwer @kianoushbk @ogi_gajic et al found that 67% of angio II recipients had favorable hemody…
RT @accpcritprn: #JournalWatch Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use “...for vasopressor-refractory…
Reviewing a recent study on the safety and effectiveness of synthetic angiotensin II for vasodilatory shock unresponsive to other vasopressors, highlighting patient responses, blood pressure improvements, and associated…
RT @accpcritprn: #JournalWatch Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use “...for vasopressor-refractory…
RT @accpcritprn: #JournalWatch Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use “...for vasopressor-refractory…
RT @accpcritprn: #JournalWatch Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use “...for vasopressor-refractory…
RT @accpcritprn: #JournalWatch Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use “...for vasopressor-refractory…
RT @accpcritprn: #JournalWatch Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use “...for vasopressor-refractory…
RT @accpcritprn: #JournalWatch Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use “...for vasopressor-refractory…
RT @accpcritprn: #JournalWatch Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use “...for vasopressor-refractory…
#JournalWatch Angiotensin II Infusion for Shock: A Multicenter Study of Postmarketing Use “...for vasopressor-refractory shock, 67% of angiotensin II recipients [had] a favorable hemodynamic response.” #critPRN #PharmICU @pwierusz @erin_barreto https://t.co/yE6FZxAXHo
Collaboration is KEY to learning more about the role of AngII in refractory shock @KyleGunnerson @umichCVC @UMichPharmacy READ more
RT @MayoPCCM: @pwierusz @erin_barreto @EricaWittwer @kianoushbk @ogi_gajic et al found that 67% of angio II recipients had favorable hemody…
RT @MayoPCCM: @pwierusz @erin_barreto @EricaWittwer @kianoushbk @ogi_gajic et al found that 67% of angio II recipients had favorable hemody…
@pwierusz @erin_barreto @EricaWittwer @kianoushbk @ogi_gajic et al found that 67% of angio II recipients had favorable hemodynamic response and mortality. Pts w/ lower lactate and those receiving vasopressin were more likely to respond to angio II. https://t.co/ACLlmVXyhb
Post-marketing use for vasopressor-refractory shock, 67% of angiotensin II recipients experienced favorable hemodynamic response. Pts w/ lower lactate or on vasopressin were more likely to respond. Angio II responders had lower mortality @SCCM @accpchest https://t.co/meRN3ROs01
AP
M
AM
AM
EB
EC
DP
VB
BB
K
SS
KG
AH